Occudo Quantitative Strategies’s Axsome Therapeutics AXSM Stock Holding History

Occudo Quantitative Strategies’s Portfolio AXSM Stock Details AXSM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$2.87M	Buy	+13,826	New	+$2.39M	0.16%	199
2023 Q4	–	Sell	-2,864	Closed	-$200K	–	803
2023 Q3	$200K	Buy	+2,864	New	+$214K	0.03%	800
2021 Q4	–	Sell	-37,505	Closed	-$1.24M	–	1061
2021 Q3	$1.24M	Buy	+37,505	New	+$1.46M	0.15%	203
2021 Q1	–	Sell	-3,971	Closed	-$324K	–	747
2020 Q4	$324K	Buy	+3,971	New	+$297K	0.1%	387

Other funds holding AXSM

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Occudo Quantitative Strategies's AXSM Position: Q1 2026 in Review

Occudo Quantitative Strategies opened a new position in Axsome Therapeutics (AXSM) in Q1 2026: 13,826 shares worth $2.87M. The stake represents 0.16% of the portfolio and ranks #199 among its holdings. This is a return to the name: Occudo Quantitative Strategies previously reported a position in AXSM as recently as Q3 2023.

Occudo Quantitative Strategies first reported a position in AXSM in Q4 2020 and has held it in 4 quarters since. 409 funds tracked by Wall St. Rank hold AXSM as of Q1 2026.

Occudo Quantitative Strategies held 13,826 shares of Axsome Therapeutics worth $2.87M as of Q1 2026.
Axsome Therapeutics was a new Occudo Quantitative Strategies position in Q1 2026.
Axsome Therapeutics made up 0.16% of Occudo Quantitative Strategies's portfolio in Q1 2026, its #199 holding.
Occudo Quantitative Strategies first reported a position in Axsome Therapeutics in Q4 2020 and has held it in 4 quarters since.
409 funds tracked by Wall St. Rank held Axsome Therapeutics as of Q1 2026.

Based on Occudo Quantitative Strategies's 13F filing for Q1 2026, filed 15 May 2026.